Subscribe To Our Free Newsletter |
Alembic Pharma slips 2% despite robust Q2 results
The Group has posted a net profit after tax and share of profit of associates of Rs. 2889.00 million for the quarter ended September 30, 2015 as compared to Rs. 772.70 mn for the quarter ended September 30, 2014. Total Income has increased from Rs. 5472.20 mn for the quarter ended September 30, 2014 to Rs. 10088.10 million for the quarter ended September 30, 2015.